The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 15, 2020

Filed:

Mar. 15, 2019
Applicant:

Deutsches Rheuma-forschungszentrum Berlin, Berlin, DE;

Inventors:

Chiara Romagnani, Berlin, DE;

Timo Rückert, Berlin, DE;

Quirin Hammer, Berlin, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/08 (2019.01); A61P 31/20 (2006.01); A61P 35/02 (2006.01); A61P 35/00 (2006.01); A61K 35/17 (2015.01); A61K 38/20 (2006.01); A61K 45/06 (2006.01); C12N 5/0783 (2010.01);
U.S. Cl.
CPC ...
A61K 38/08 (2013.01); A61K 35/17 (2013.01); A61K 38/20 (2013.01); A61K 38/208 (2013.01); A61K 38/2086 (2013.01); A61K 45/06 (2013.01); A61P 31/20 (2018.01); A61P 35/00 (2018.01); A61P 35/02 (2018.01); C12N 5/0638 (2013.01);
Abstract

The invention relates to an isolated peptide for use as a medicament, wherein said peptide has 9 to 30 amino acids and comprises or consists of an amino acid sequence according to SEQ ID NO 1 (VMAPRTLXL), wherein X is an amino acid with a hydrophobic side chain (A, I, L, F, V, P, G), preferably V, L, I or F. The invention further relates to the peptide of the invention for use as a medicament to expand and/or activate NKG2C+ natural killer (NK) cells. The invention further relates to the peptide of the invention for use in the treatment and/or prevention of a medical condition associated with pathogenic cells expressing HLA-E and a peptide comprising an amino acid sequence according to SEQ ID NO 1 or 2. Additionally, the invention relates to a genetically modified virus encoding a peptide comprising or consisting of a polypeptide of the invention for use as a medicament to expand and/or activate NKG2C+ natural killer (NK) cells.


Find Patent Forward Citations

Loading…